Dr. Stacy Lindborg is president and CEO of IMUNON, a clinical-stage company in phase 3 development with a lead DNA-mediated immunotherapy for advanced ovarian cancer. Dr. Lindborg has worked in the ...

Creative Biolabs is helping researchers overcome challenges of gene therapy research by providing analytical testing ...

AGC Biologics signed a licensing agreement to use Asimov’s lentiviral packaging system, enabling production from a single-plasmid transfection.

UVA Health scientists are reporting promising success as they pioneer a new way to create vaccines far more quickly, nimbly ...

Elegen sets a new benchmark for clonal, cell-free synthetic DNA with ENFINIA, delivering unmatched length and accuracy from ...

In this second of three articles on The Sunday Times top 100 tech companies list, pharmaphorum is focusing on the first nine ...

The Seattle facility of AGC Biologics, your friendly CDMO expert, has received a Good Manufacturing Practices Certification from Agência Nacional de Vigilância Sanitária (Anvisa), Brazil's health ...

Cotality has been named a winner in Glassdoor's inaugural Best Places to Work in Technology and AI for 2026. The list is a new addition to Glassdoor's 18th annual Employees' Choice Awards, honoring ...

Ovarian cancer standard of care has not advanced in over 30 years, but a new DNA-based immunotherapy could be a gamechanger, showing major survival gains in clinical trials.

Thermo Fisher Scientific Inc. TMO is slated to release fourth-quarter 2025 results on Jan. 29, before market open. In the last reported quarter, earnings of $5.79 per share beat the Zacks Consensus ...

A bacterial biosensor created by researchers from The Hebrew University of Jerusalem (Rehovot, Israel) lights up in the ...

Aircraft wing-shaped structures inside tiny channels produce consistent drug delivery particles at any scale, from small laboratory tests to factory production, while substantially cutting costs.